Data as of Nov 21
| -0.01 / -0.01%|
The 24 analysts offering 12-month price forecasts for Gilead Sciences Inc have a median target of 126.50, with a high estimate of 170.00 and a low estimate of 65.00. The median estimate represents a +25.77% increase from the last price of 100.58.
The current consensus among 26 polled investment analysts is to Buy stock in Gilead Sciences Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.